Targeted Delivery of Natural Bioactives and Lipid-nanocargos against Signaling Pathways Involved in Skin Cancer
- 22 December 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 28 (39), 8003-8035
- https://doi.org/10.2174/0929867327666201104151752
Abstract
At present, skin cancer is a widespread malignancy in human beings. Among diverse population types, Caucasian populations are much more prone in comparison to darker skin populations due to the comparative lack of skin pigmentation. Skin cancer is divided into malignant and non-melanoma skin cancer, which is additionally categorized as basal and squamous cell carcinoma. The exposure to ultraviolet radiation, chemical carcinogen (polycyclic aromatic hydrocarbons, arsenic, tar, etc.), and viruses (herpes virus, human papillomavirus, and human T-cell leukemia virus type-1) are major contributing factors of skin cancer. There are distinct pathways available through which skin cancer develops, such as the JAKSTAT pathway, Akt pathway, MAPKs signaling pathway, Wnt signaling pathway, to name a few. Currently, several targeted treatments are available, such as monoclonal antibodies, which have dramatically changed the line of treatment of this disease but possess major therapeutic limitations. Thus, recently many phytochemicals have been evaluated either alone or in combination with the existing synthetic drugs to overcome their limitations and have found to play a promising role in the prevention and treatment. In this review, complete tracery of skin cancer, starting from the signaling pathways involved, newer developed drugs with their targets and limitations along with the emerging role of natural products alone or in combination as potent anticancer agents and their molecular mechanism involved has been discussed. Apart from this, various nanocargos have also been mentioned here, which can play a significant role in the management and treatment of different types of skin cancer.Funding Information
- Indian Council of Medical Research (ICMR) SRF (3/2/2/45/2018)
This publication has 151 references indexed in Scilit:
- Phase 1 Study of Erlotinib Plus Radiation Therapy in Patients With Advanced Cutaneous Squamous Cell CarcinomaEndocrine, 2013
- Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapyLipids in Health and Disease, 2012
- Molecular mechanisms of garlic‐derived allyl sulfides in the inhibition of skin cancer progressionAnnals of the New York Academy of Sciences, 2012
- RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and TherapyDermatology Research and Practice, 2011
- 7,3′,4′-Trihydroxyisoflavone, a Metabolite of the Soy Isoflavone Daidzein, Suppresses Ultraviolet B-induced Skin Cancer by Targeting Cot and MKK4Online Journal of Public Health Informatics, 2011
- Targeting BRAF in Advanced Melanoma: A First Step toward Manageable DiseaseClinical Cancer Research, 2011
- Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A‐431) cellsBritish Journal of Pharmacology, 2010
- Use of liposomes as drug delivery vehicles for treatment of melanomaPigment Cell & Melanoma Research, 2009
- Multi-targeted therapy of cancer by genisteinCancer Letters, 2008
- Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in ratsBritish Journal of Pharmacology, 2008